Astec Lifesciences Ltd. - Research Center
533138 ASTEC Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
19.61 |
19.60 |
19.59 |
19.57 |
19.55 |
Share application money
Preference share capital
Reserves & surplus
398.83 |
376.09 |
288.70 |
226.20 |
182.14 |
Secured loans
341.18 |
279.37 |
187.03 |
98.71 |
175.67 |
Unsecured loans
Total
759.97 |
675.35 |
495.73 |
345.15 |
378.13 |
Gross block
480.69 |
471.00 |
310.55 |
267.02 |
217.47 |
Less : revaluation reserve
Less : accumulated depreciation
162.34 |
131.12 |
97.87 |
73.34 |
50.83 |
Net block
318.35 |
339.88 |
212.67 |
193.68 |
166.64 |
Capital work-in-progress
126.60 |
22.82 |
115.71 |
24.11 |
18.98 |
Investments
Current assets, loans & advances
533.47 |
533.58 |
349.09 |
353.82 |
274.97 |
Less : current liabilities & provisions
218.87 |
221.36 |
182.16 |
226.95 |
82.95 |
Total net current assets
314.59 |
312.22 |
166.92 |
126.87 |
192.02 |
Miscellaneous expenses not written
Total
759.97 |
675.35 |
495.73 |
345.15 |
378.13 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
256.13 |
215.22 |
233.72 |
209.82 |
124.24 |
Number of equity sharesoutstanding (Lacs)
196.06 |
195.98 |
195.88 |
195.68 |
195.53 |